Mezzion Pharma Co.Ltd (140410) — Cash Flow Reinvestment Rate
Mezzion Pharma Co.Ltd (140410) has a Cash Flow Reinvestment Rate of 2.33x as of September 2023, reinvesting ₩11.01 Billion (capex ₩5.46 Billion plus investments ₩-5.55 Billion) from operating cash flow of ₩4.73 Billion. Check 140410 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mezzion Pharma Co.Ltd Cash Flow Reinvestment Rate (2012–2015)
Historical reinvestment intensity for Mezzion Pharma Co.Ltd across 2 annual periods. Explore Mezzion Pharma Co.Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Mezzion Pharma Co.Ltd (2012–2015)
Year-by-year capital reinvestment analysis for Mezzion Pharma Co.Ltd. For live market cap and broader valuation context, see Mezzion Pharma Co.Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 0.55x | ₩983.20 Million | ₩1.77 Billion | ₩564.10 Million | ▲ +77.0% |
| 2012 | 0.31x | ₩983.20 Million | ₩3.14 Billion | ₩564.10 Million | — |